Comparative Role of Peptide Leukotrienes and Histamine in the Development of Nasal Mucosal Swelling in Nasal Allergy

Abstract

To evaluate the importance of histamine and peptide leukotrienes (LTs) in the development of nasal mucosal swelling in nasal allergy, H₁ receptor antagonist (mequitazine, 6 mg, in 2 divided doses, Rhône-Poulenc Rorer, France) and LT receptor antagonist (ONO-1078, pranlukast, 450 mg, in 2 divided doses, Ono Pharmaceutical Co, Ltd, Osaka) were administered orally for 7 days to 16 subjects with perennial nasal allergy to house dust mites, and the effects of receptor blockers of these chemical mediators on the effective cross-sectional area of the nasal cavity (ECA) at rest, at exercise load, at antigen challenge, and at exercise load following antigen challenge were studied. After the administration of H₁ receptor antagonist, ECAs at all measurement points slightly increased, but no statistical significance was observed. On the other hand, LT receptor antagonist inhibited ECAs 10 minutes after exercise load, just after the end of antigen challenge, 10 minutes later, and at exercise load following antigen challenge with statistical significance. These results suggest that LTs are involved markedly, and histamine slightly, in the development of nasal mucosal swelling in nasal allergy.

Keywords

nasal allergy nasal mucosal swelling peptide leukotriene receptor antagonist

Get full access to this article

View all access options for this article.

References

Lundblad

. Protective reflexes and vascular effects in the nasal mucosa elicited by activation of capsaicin-sensitive substance P—immunoreactive trigeminal neurons. Acta Physiol Scand Suppl 1984(suppl 529).

Stjärne

Lundblad

Anggärd

. Local capsaicin treatment of the nasal mucosa reduces symptoms in patients with nonallergic nasal hyperreactivity. Am J Rhinol 1991; 5: 145–51.

LaCroix

Buvelot

Polla

Lundberg

. Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin. Clin Exp Allergy 1991; 21: 595–600.

Konno

Nagata

Nomoto

Motosugi

Terada

. Role of capsaicin-sensitive trigeminal nerves in development of hyperreactive nasal symptoms in guinea pig model of nasal allergy. Ann Otol Rhinol Laryngol 1995; 104: 730–5.

Konno

Terada

Okamoto

Togawa

. The role of chemical mediators and mucosal hyperreactivity in nasal hypersecretion in nasal allergy. J Allergy Clin Immunol 1987; 79: 620–6.

Raphael

Meredith

Baraniuk

Druce

Banks

Kaliner

. The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 1989; 139: 791–800.

Katahashi

Konno

. Effect of tachykinin receptor antagonists, FK224 and FK888 in guinea pig model of nasal allergy. Rhinology 1997; 35: 63–6.

Konno

Numata

Terada

Hanazawa

Nagata

Motosugi

. Role of substance P in the vascular response of nasal mucosa in nasal allergy. Ann Otol Rhinol Laryngol 1996; 105: 648–53.

Obata

Okada

Motoishi

Kakagawa

Terawaki

Aishita

. In vitro antagonism of ONO-1078, a newly developed anti-asthma agent, against peptide leukotrienes in isolated guinea pig tissues. Jpn J Pharmacol 1992; 60: 227–37.

10.

Okuda

. Fundamental and clinical studies on nasal allergy. Otologia Fukuoka 1974; 20: 297–344.

11.

Konno

Terada

Nomoto

. The effect of psychic stimulation on plasma catecholamine concentrations and nasal patency in patients with nasal allergy. Ann Otol Rhinol Laryngol 1994; 103: 375–82.

12.

Naclerio

Meier

Kagey-Sobotka

. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128: 597–602.

13.

Naclerio

Proud

Togias

. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65–9.

14.

Creticos

Peters

Adkinson

. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984; 310: 1626–30.

15.

Terada

Ando

Ito

. Nasal allergy and leukotriene. II. Kinetics of peptide leukotrienes and inflammatory cells in nasal lavage fluid after antigen challenge. J Otolaryngol Jpn 1989; 92: 1337–44.

16.

Dahlen

Bjork

Arfors

Hammarstrom

Lindgren

Samuelsson

. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules. In vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1981; 78: 3887–91.

17.

Drazen

Austen

Lewis

. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980; 77: 4354–8.

18.

Omini

Daffonchio

Berti

. Positive interaction between leukotriene C4 and histamine and other mediators on vascular tissues. Prostaglandins 1985; 29: 1009–20.

19.

Bisgaard

Olsson

Bende

. Leukotriene D4 increases nasal blood flow in humans. Prostaglandins 1984; 27: 599–605.

20.

Okuda

Watase

Mezawa

Liu

. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1987; 60: 537–40.

21.

Shirasaki

Asakura

Kojima

Sohma

Kataura

. The roles of histamine, leukotriene C4 and bradykinin on nasal vascular permeability in experimental nasal allergy of guinea pigs. Rhinology 1992; 30: 41–8.

22.

Peck

Piper

Williams

. The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin. Prostaglandins 1981; 21: 315–21.

23.

Bisgaard

Kristensen

Sondergaard

. The effect of leukotrienes C4 and D4 on cutaneous blood flow in humans. Prostaglandins 1982; 23: 797–801.

24.

Konno

Togawa

Itasaka

. Neurophysiological mechanisms of shrinkage of nasal mucosa induced by exercise. Auris Nasus Larynx 1982; 9: 81–90.

25.

Johnson

Chinn

Chow

Bach

Nadel

. Leukotriene C4 enhances mucus production from submucosal glands in canine trachea in vivo. Int J Immunopharmacol 1983; 5: 391–6.